Wave Life Sciences (WVE) stock slides 6% — what traders are watching next
New York, Jan 4, 2026, 12:46 ET — Market closed Wave Life Sciences shares closed down 6.2% on Friday at $15.95, with the Nasdaq-listed biotech swinging between $15.53 and $17.23 in the session. The drop matters because Wave’s stock has become a high-beta proxy for investor appetite for next-generation obesity treatments, where early clinical signals can move valuations sharply. The next company update investors care about is already on the calendar: Wave has guided to additional INLIGHT trial data in the first quarter. SEC Wave is developing RNA medicines, including WVE-007, a small interfering RNA (siRNA) therapy that aims to